This cohort study uses data from an atrial fibrillation registry to describe the proportion of patients on warfarin who had stable INR values over an 18-month period.
This JAMA Clinical Guidelines Synopsis summarizes the American Heart Association/American Stroke Association (AHA/ASA) 2014 guidelines on primary prevention of stroke.
This Medical Letter review summarizes the newly available oral anticoagulants and compares them with commonly prescribed warfarin.
This Viewpoint proposes widespread screening for atrial fibrillation using accessible and inexpensive means as a public health intervention for preventing stroke.
This cohort study assessed the accuracy of the CHA2DS2-VASc score for predicting ischemic stroke, thromboembolism, and death in patients with heart failure with and without atrial fibrillation.
This review article reports that therapy for atrial fibrillation should include rate control for all patients, but maintenance of sinus rhythm with drugs or catheter ablation should be considered on an individual patient basis.
This JAMA Clinical Guidelines Synopsis article summarizes the evidence for management of anticoagulation therapy in patients with atrial fibrillation.
This From the Medical Letter article reviews the pharmacokinetics and indications for edoxaban, an oral anticoagulant for the treatment of venous thromoboembolism and prevention of stroke in patients with AF.
This narrative review summarizes stroke risk prediction tools and strategies to prevent stroke in patients with atrial fibrillation.
This retrospective cohort study in Germany reports on analyses of the treatment of oral anticoagulation–associated intracerebral hemorrhage and its association with rates of hematoma enlargement, ischemic and hemorrhagic events with or without resumption of oral anticoagulation, and long-term functional outcome.
This randomized clinical trial reports that mechanical left atrial appendage closure was noninferior to warfarin for preventing stroke, systemic embolism, and cardiovascular death.
Imazio and coauthors conducted a randomized clinical trial among 360 patients undergoing cardiac surgery to determine the efficacy and safety of perioperative use of oral colchicine in reducing postpericardiotomy syndrome, postoperative atrial fibrillation, and postoperative pericardial effusions.
Gialdini and coauthors report on perioperative atrial fibrillation and the long-term risk of ischemic stroke.